Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
Completed
- Conditions
- Plaque Psoriasis
- Registration Number
- NCT00227240
- Lead Sponsor
- Pfizer
- Brief Summary
The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 753
Inclusion Criteria
- Proven diagnosis of Plaque Psoriasis
Read More
Exclusion Criteria
- Contraindications according to SmPC of Enbrel
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Pfizer Investigational Site
🇩🇪Munich, Germany